Argentina Approves New Foot-and-Mouth Disease Vaccine from Colombian Lab
- Published:
- First detected:
Insights by Echo AI
Argentina's government is set to announce the approval of a new foot-and-mouth disease vaccine produced by a Colombian laboratory, Vecol, which already supplies Uruguay. This move is seen as a significant step in liberalizing the market, previously dominated by Biogénesis Bagó. The new vaccine, Aftogán, is expected to increase competition and potentially reduce prices. The market for foot-and-mouth disease vaccines is worth around USD 150 million annually in Argentina.
Source coverage
Aggregated
2
records merged
X / Twitter
1
1 unique
Telegram
0
0 unique
RSS
1
1 unique
2 Sources
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
